Startup entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Compass Pathways plc, the most common co-covered peer. Each story carries 28 original sources on average, compared with 5.5 for the broader beat in this window.
Last mentioned: Feb 20, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Compass Pathways plc, the most common co-covered peer. Each story carries 28 original sources on average, compared with 5.5 for the broader beat in this window. At 7, the average consequence score sits below the same-window beat average of 7.4. We currently track 1 Startup story that mention Ocular Therapeutix, Inc., all published on February 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 39 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ocular Therapeutix, Inc.. Shared-story counts are live from our verified record — not editorial picks.
A volatile earnings season is highlighting a sharp divergence in biotech valuations, with Compass Pathways surging on psychedelic therapy success while others face headwinds. Simultaneously, Robinhood's entry into the venture fund IPO market signals a new era of retail access to private-market-style assets.
Ocular Therapeutix, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
